FDA NDC Directory · JSON-LD · Markdown

Decitabine

NDC 68001-642 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA215355
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsDECITABINE (50 mg/10mL)
Marketing started20250501
Package count1

External sources

Source: openFDA. Public-domain (CC0).